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INTRODUCTION
Pulmonary tuberculosis remains a major public health prob-
lem and economic burden worldwide. Despite advances in
chemotherapy policies, the prevalence of tuberculosis is still
high. Resistance to anti-tuberculosis drugs is an increasing
problem in many parts of the world. Therefore, quantifying
drug-resistance rates and identifying potential risk factors are
critical for controlling drug-resistant strains (1). 
In the Republic of Korea, which has an intermediate bur-
den of tuberculosis (2), military service is compulsory for all
young men. Military personnel are at risk for tuberculosis due
to crowded living conditions and the specific age groups in-
volved (3, 4). In the Korean military, the incidence of pul-
monary tuberculosis has been declining steadily; however it
is still high (5). In response, the Korean military has imple-
mented a strict tuberculosis control program, which includes
the followings. At the time of enlistment, tuberculosis pa-
tients who have undergone treatment for less than six months
are deferred; and military service is rejected for patients with
a history of tuberculosis resistance to isoniazid (INH) or ri-
fampicin (RFP), or for those who have had a positive culture
after three months of treatment. Following a physical exam-
ination during conscription, chest radiograph screening is per-
formed on all recruits and further evaluations are carried out
if there are any suspicious active lesion. During military ser-
vice, diagnosis and treatment of pulmonary tuberculosis is per-
formed according to the recommended guidelines of both
the National Tuberculosis Program and the Korean Acade-
my of Tuberculosis and Respiratory Disease (6). This includes
isolation of the patient from military units and undertaking
directly observed therapy for at least two weeks.
Despite these efforts, tuberculosis outbreaks are still report-
ed in the Korean military (7). Furthermore, because drug sus-
ceptibility tests can only be confirmed two months after di-
agnosis (8), multidrug-resistant tuberculosis (MDR TB) out-
breaks are a major concern when the index case lives and works
in a crowded unit. In this type of situation, it is important
to know the current status of all individuals and to identify
personnel that have a high probability of contracting MDR
TB, prior to the arrival of report of drug susceptibility test.
However, no data are available regarding the drug resistance
rates and risk factors associated with MDR TB among young
soldiers in a communal setting. Here, we evaluated the preva-
lence of first-line drug resistant tuberculosis and risk factors
associated with MDR TB in young Korean soldiers. 
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Multidrug-resistant Pulmonary Tuberculosis Among Young Korean 
Soldiers in a Communal Setting
The goal of this study was to evaluate the prevalence of first-line anti-tuberculosis
drug resistance and risk factors associated with multidrug-resistant tuberculosis
(MDR TB) among young soldiers in the Korean military, which has a strict tubercu-
losis control program. All patients with culture-confirmed pulmonary tuberculosis
during their service at the Armed Forces Capital Hospital from January 2001 to
December 2006 were enrolled in the study. Drug resistant Mycobacterium tuber-
culosis was isolated from 18 patients (12.2%) and multidrug-resistant M. tubercu-
losis was isolated from 12 patients (8.1%). Previous treatment of tuberculosis and
the presence of a cavity on the patient’s chest computed tomography scan were
associated with MDR TB; military rank, smoking habits, and positive acid-fast bacilli
smears were not associated with MDR TB. In a multiple logistic regression analysis,
previous treatment of tuberculosis was a significant independent risk factor for MDR
TB (odds ratio 6.12, 95% confidence interval 1.53-24.46). The prevalence of drug
resistant tuberculosis among young soldiers in the Korean military was moderately
high and the majority of resistant cases were found in patients who had undergone
previous treatment of tuberculosis. Based on our results, we suggest that relapsed
tuberculosis cases within communal settings should be cautiously managed until
the drug susceptibility tests report is completed, even if previous treatment results
were satisfactory.
Key Words : Tuberculosis, Pulmonary; Tuberculosis, Multidrug-Resistant; Korea; Military Personnel
Received : 29 February 2008
Accepted : 23 August 2008MDR Tuberculosis in Korean Soldiers 593
MATERIALS AND METHODS
Study population and design
All patients enrolled in the study were diagnosed with pul-
monary tuberculosis by positive culture at the Armed Forces
Capital Hospital between January 2001 and December 2006.
Patients referred from other military hospitals, patients with-
out drug susceptibility test reports, and sergeants (higher rank
than staff sergeant) and officers who did not live in commu-
nal settings were excluded from the study. The Armed Forces
Capital Hospital (a referral military hospital) is responsible
for maintaining the health of soldiers who work in the area
adjacent to Seoul, the capital city of the Republic of Korea.
Military populations occupying ranks lower than sergeant
or officer reside in the first-assigned area throughout their
military service. Therefore, our study population appears to
be a representative sample of all young soldiers at risk for
pulmonary tuberculosis that are stationed in the area adja-
cent to Seoul. 
We retrospectively reviewed medical records, laboratory
data, radiological findings, and personal detailed reports of
all enrolled patients. In addition, we obtained sputum acid-
fast bacilli (AFB) smear results, smoking histories, previous
treatment history for tuberculosis (>1 month), and military
rank at diagnosis. Because ranks of soldiers performing com-
pulsory military service are promoted at regular intervals of 6
months (with rare exceptions), military rank reflects the time
from enlistment to diagnosis.
Laboratory methods
Clinical specimens were stained using the Ziehl-Neelsen
method (9). Microscopy results for sputum smears were re-
ported semi-quantitatively; a positive smear was defined as
>1 AFB per 100 in a field under high-power (9). Clinical speci-
mens were cultured on 3% Ogawa medium. Mycobacterium
tuberculosis was confirmed in cultures using measurements of
growth rate, colony morphology, and pigmentation. Addition-
ally, commercial biochemical tests were performed (BLL Taxo
TB niacin test; BD Diagnostics, Franklin Lakes, NJ, U.S.A.).
All isolates of M. tuberculosiswere referred to the Korean Insti-
tute of Tuberculosis for drugs usceptibility test. Drug resis-
tance was determined by the absolute concentration method.
Briefly, Lowenstein-Jensen medium containing anti-tuber-
culosis drugs were used at the following critical concentra-
tions: INH 0.2 μ g/mL; RMP 40 μ g/mL; ethambutol (EMB)
2.0 μ g/mL (10). Pyrazinamide (PZA) susceptibility was deter-
mined using the pyrazinamidase test (11). 
Statistical analysis 
Data are presented as the percentage and absolute frequen-
cy for categorical variables and the median and range for con-
tinuous variables. We compared the clinical and radiologi-
cal findings between patients with MDR TB and those with
non-MDR TB. Frequencies were analyzed using either a chi-
square test or Fisher’s exact test, where appropriate. A mul-
tiple logistic regression analysis was used to identify indepen-
dent risk factors associated with MDR TB. The development
of MDR TB was the dependent variable and all clinical and
radiological findings were the independent variables in the
forward stepwise multiple logistic regression model. All data
were analyzed by using SPSS 13.0. (SPSS Inc, Chicago, IL,
U.S.A.). 
RESULTS
A total of 198 patients were diagnosed with culture-con-
firmed pulmonary tuberculosis at the Armed Forces Capital
Hospital between January 2001 and December 2006. Of these,
24 patients, consisted of 20 sergeants, two officers, and four
individuals without drug susceptibility test reports, were ex-
cluded because they were referred from other military hospi-
tals. Therefore, the total number of patients enrolled in the
study was 148. The median age was 21 yr (range: 20-22 yr)
and all patients were male. Sixty-five patients (43.9%) were
current smokers. AFB sputum smears were positive in 90
patients (60.8%). One hundred-nineteen patients (80.4%)
were new cases, and 29 (19.6%) had a history of previous treat-
ment of tuberculosis; 23 (79.3%) had completed treatment
with confirmation of cure, but six (20.7%) had not been con-
firmed the cure after treatment for more than 6 months. Medi-
an length of time from completion of previous treatment prior
to diagnosis is two years (6 months-7 yr). Chest computer-
ized tomography (CT) scans were performed on all enrolled
patients; and 63 patients (42.6%) showed the presence of a
cavity on the chest CT. 
M. tuberculosis, that was resistant to at least one drug, was
isolated from 18 patients (12.2%; Table 1). Drug resistance
rates were higher in previously treated cases (24.1%) com-
pared to new cases (9.2%, P=0.028; Table 1). Multidrug-
resistant M. tuberculosis was isolated from 12 patients (8.1%).
INH, isoniazid; RFP, rifampicin; EMB, ethambutol; PZA, pyrazinamide.
New cases
(n=119)
Previously
treated
cases
(n=29)
Total
(n=148)
P
value
Resistance to any drug 11 (9.2%) 7 (24.1%) 18 (12.2%) 0.028
INH 10 (8.4%) 7 (24.1%) 17 (11.5%)
RFP 5 (4.2%) 7 (24.1%) 12 (8.1%)
EMB 5 (4.2%) 6 (20.7%) 11 (7.4%)
PZA 3 (2.5%) 2 (6.9%) 5 (3.4%)
Multi-drug resistance 5 (4.2%) 7 (24.1%) 12 (8.1%) 0.002
Table 1. First-line drug resistance in pulmonary tuberculosis
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The rate of MDR TB was also higher in previously treated
cases (24.1%) compared to new cases (4.2%, P=0.002; Table 1).
There was no relationship between the development of
MDR TB and military rank (P=0.225, test for trends; Fig.
1). In addition, no significant differences were observed in
terms of smoking history or sputum smear results between
groups (P=0.658 and 0.367, respectively; Table 2). Patients
with MDR TB were more likely to have received previous
treatment of tuberculosis compared to patients with non-MDR
TB (58.3% vs. 16.2%, P=0.002; Table 2). In addition, pa-
tients with MDR TB were more likely to have exhibited a
cavity on the chest CT (75.0%) compared to patients with
non-MDR TB (39.7%, P=0.018; Table 2). In the multiple
logistic regression analysis, previous treatment of tuberculo-
sis was a significant independent risk factor for MDR TB
(odds ratio 6.12, 95% confidence interval 1.53-24.46). How-
ever, military rank, smoking, positive AFB smear and cavity
on chest CT were not associated with development of MDR
TB (Table 2).
DISCUSSION
In this study, we evaluated the prevalence of drug resistant
tuberculosis and identified risk factors associated with MDR
TB in individuals in the Korean military. The proportion of
MDR TB was 8.1%; and previous treatment of tuberculosis
was the only significant independent risk factor for MDR TB
among young Korean soldiers with culture-confirmed pul-
monary tuberculosis.
In a recent drug resistance survey among Korean patients in
their twenties, drug resistance rates are 14.3% for new cases
and 22.5% for previously treated cases, respectively (10). These
proportions are similar to those found in our study. However,
this result is somewhat difficult to accept when considering
that a well-organized tuberculosis control program should
reduce drug resistant tuberculosis (12, 13), and when Kore-
an military has a stricter control program than the private sec-
tor. However, communal living and intense physical train-
ing in military life may diminish the effectiveness of this strict
control program. Other studies have reported that impris-
onment is associated with drug resistant tuberculosis (14).
Previous treatment of tuberculosis has been consistently
reported as the risk factor within various clinical conditions
and populations (14-20). We found that previous treatment
of tuberculosis was strongly associated with MDR TB in Kore-
an military personnels. It is intriguing given that any person
who has history of MDR TB, a poor treatment outcome, in-
complete treatment for tuberculosis, or suspicious active lesion
of tuberculosis on chest radiograph screening was excluded
from enlistment. These results suggest that previous treat-
ment can be a risk factor for drug resistance even if the treat-
ment had a favorable course and if the patient had been clin-
ically cured. Chest cavities are also associated with MDR TB
in some reports (15, 17, 20). However, in almost all previous
studies, cavities were confirmed only by chest radiograph, and
some cavities may have been missed. To minimize this pos-
sibility, chest CT scans were performed on all patients in our
study. We found that the presence of a cavity was associated
with MDR TB; however, this result was not significant in a
multivariate analysis. 
This study has several limitations. First, this study was per-
formed in a central referral military hospital where the most
severe cases are treated. We cannot exclude the possibility that
particularly severe or complicated cases were inadvertently
included in this study. However, we excluded patients referred
from other military hospitals to avoid this selection bias. Sec-
ond, some parts of the patients’ medical history at conscrip-
tion depend on the soldier’s memory. We attempted to obtain
Non-MDR
(n=136)
MDR
(n=12)
P value
Multivariate analysis
OR 95% CI P value
AFB, acid-fast bacilli; CT, computed tomography; OR, odds ratio; CI, confidence interval.
Military rank (private:private first class:corporal:sergeant) 14:22:47:53 0:6:4:2 0.225 0.91 0.46-1.79 0.782
Smoking 59 (43.4%) 6 (50.0%) 0.658 1.12 0.30-4.12 0.869
Previous tuberculosis treatment 22 (16.2%) 7 (58.3%) 0.002 6.12 1.53-24.47 0.010
Positive AFB smear  81 (59.6%) 9 (75.0%) 0.367 1.59 0.35-7.26 0.553
Cavity on CT 54 (39.7%) 9 (75.0%) 0.018 3.31 0.77-14.30 0.109
Table 2. Clinical characteristics of young Korean soldiers with pulmonary tuberculosis with or without multi-drug resistance (MDR)
Fig. 1. Multi-drug resistance (MDR) among pulmonary tuberculo-
sis (TB) cases according to military rank.
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medical records prior to the conscription examination; how-
ever, these records could not be traced in some cases. Difficul-
ty in tracing back past documents may be a potential weak-
ness in the Korean military TB control program. In addition,
treatment history of tuberculosis before military service was
analysed depending on the memory of soldiers himself in most
cases. This was inevitable because of low notification rate of
tuberculosis in private sector and difficulty in getting past
medical record during military service. Third, relatively small
number of tuberculosis cases was enrolled. Although our study
population was a representative sample of young soldiers at
risk for pulmonary tubeculosis that are stationed in the area
adjacent to Seoul, it may be a small portion of patients con-
sidering the incidence of tuberculosis in Korean military (5). 
In conclusion, the prevalence of drug resistant tuberculo-
sis among young soldiers in the Korean military was still high,
even with a strict tuberculosis control program in place. Based
on our results and the limited data available, we suggest that
relapsed tuberculosis cases in the military should be cautious-
ly managed until the drug susceptibility test report is com-
pleted, even if the previous treatment results were satisfac-
tory. 
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